Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Nanjing Sinolife United Company Limited (3332.HK)
Nanjing, CN
Nanjing Sinolife United Company Limited functions as an investment holding entity primarily involved in the manufacturing, processing, and global distribution of nutritional supplements. Its operations span the People's Republic of China, Australia, New Zealand, Vietnam, and various international markets. The firm additionally produces and markets cosmetics and skincare items, while also undertaking the trading, retail, and testing of pre-packaged health food products. Products are sold under well-known brands such as Good Health, Zhongsheng, Hejian, and Cobayer, primarily via its comprehensive network of retail outlets. Distribution also encompasses sales through distributors, television shopping channels, online e-commerce platforms, chain pharmacies, specialized health food supermarkets, and tourist souvenir shops. The company, which has been headquartered in Nanjing, China, since its establishment in 1999.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | -5.80% | -11.36% | -53.57% | -53.01% | -48.68% | -58.51% | +48.85% | +13.37% | -93.37% | -92.67% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Household & Personal Products: +3.3%+3.4% ★ Q4'25: +27.7% (vs Q4'23)
-
EPS growth Household & Personal Products: +8.8%-28.5% Q4'25: -62.2% (vs Q4'23)
-
FCF margin FCF growth · Household & Personal Products: +44.8%+7.2% Q4'25: +12.7% (vs Q4'23)
-
EBIT margin Household & Personal Products: +9.9%+2.9% Q4'25: +1.5% (vs Q4'23)
-
ROIC Household & Personal Products: +8.2%+7.2% Q4'25: +9.3% (vs Q4'23)
-
Share dilution Household & Personal Products: +0.2%+0.0% Q4'25: +0.0% (vs Q4'23)
-
Debt / EBITDA Net debt/EBITDA · Household & Personal Products: -0.51×3.38× ★ Q4'25: 2.44× (vs Q4'23)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2013 actual |
Dec 2014 actual |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
|---|---|---|---|---|---|
| Revenue |
194.74M
est: 206.56M (-5.7%)
|
252.45M
est: 216.18M (+16.8%)
|
397.06M
est: 434.86M (-8.7%)
|
466.24M
est: 552.62M (-15.6%)
|
472.49M
est: 661.41M (-28.6%)
|
| EBITDA |
95.65M
est: 3.77M (+2,439.0%)
|
132.93M
est: 3.86M (+3,339.2%)
|
180.24M
est: 7.77M (+2,218.3%)
|
121.32M
est: 249.55M (-51.4%)
|
27.06M
est: 12.06M (+124.3%)
|
| EBIT |
92.98M
est: -6.22M (+1,595.0%)
|
130.13M
est: 79.23M (+64.2%)
|
172.43M
est: -12.84M (+1,443.4%)
|
109.92M
est: 243.55M (-54.9%)
|
15.90M
est: -19.92M (+179.9%)
|
| Net Income |
70.79M
est: 103.41M (-31.5%)
|
107.87M
est: 71.25M (+51.4%)
|
136.23M
est: 174.72M (-22.0%)
|
87.23M
est: 180.15M (-51.6%)
|
4.21M
|
| SGA |
81.14M
est: 135.17M (-40.0%)
|
101.65M
est: 138.68M (-26.7%)
|
149.54M
est: 154.20M (-3.0%)
|
217.29M
est: 196.25M (+10.7%)
|
273.85M
est: 432.81M (-36.7%)
|
| EPS |
0.12
est: 0.11 (+9.8%)
|
0.13
est: 0.09 (+41.6%)
|
0.16
est: 0.20 (-18.5%)
|
0.10
|
0.00
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-27 | A | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-26 | A | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-21 | A | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-14 | A | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-13 | A | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-12 | A | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-11 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-08 | A | 4/5 | 5/5 | 3/5 | 4/5 | 2/5 | 4/5 | 5/5 |
| 2026-05-07 | A | 4/5 | 5/5 | 3/5 | 4/5 | 2/5 | 4/5 | 5/5 |
| 2026-05-06 | A | 4/5 | 5/5 | 3/5 | 4/5 | 2/5 | 4/5 | 5/5 |
| 2026-05-05 | A | 4/5 | 5/5 | 3/5 | 4/5 | 2/5 | 4/5 | 5/5 |
| 2026-05-04 | A | 4/5 | 5/5 | 3/5 | 4/5 | 2/5 | 4/5 | 5/5 |
| 2026-04-29 | A | 4/5 | 5/5 | 2/5 | 4/5 | 2/5 | 4/5 | 5/5 |
| 2026-04-27 | A- | 4/5 | 5/5 | 2/5 | 4/5 | 2/5 | 4/5 | 4/5 |
| 2026-04-24 | A- | 4/5 | 5/5 | 2/5 | 4/5 | 2/5 | 4/5 | 4/5 |
| 2026-04-23 | A- | 4/5 | 5/5 | 2/5 | 4/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-22 | A- | 4/5 | 5/5 | 2/5 | 4/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-21 | A- | 4/5 | 5/5 | 2/5 | 4/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-20 | A- | 4/5 | 5/5 | 2/5 | 4/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-17 | A- | 4/5 | 5/5 | 2/5 | 4/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-16 | A- | 4/5 | 5/5 | 2/5 | 4/5 | 2/5 | 3/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Pinghu Gui | Executive Chairman | 4M | male |
| Yuan Zhang | Chief Executive Officer & Executive Director | 3M | female |
| Feifei Zhu | Chief Production Officer & Executive Director | 626.3K | female |
| Bin Li | Chief Financial Officer | — | male |
| Tsz Lun Yau | Joint Company Secretary | — | male |
| Jun Wu | Financial Controller | — | male |
| Hui Zhi | Joint Company Secretary | — | female |
| Jiming Song | Compliance Officer | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 3332.HK
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
